معرفی
Professor Julian Walters serves as Professor of Gastroenterology within the Department of Metabolism, Digestion and Reproduction at Imperial College London's Faculty of Medicine. He maintains active clinical and research roles at Hammersmith Hospital (Room 368, Hammersmith House) with current contact details, and is affiliated with the Centre for Translational Nutrition and Food Research.
His academic credentials include a Doctor of Science (DSc) awarded by Imperial College London, reflecting decades of scholarly contribution to gastrointestinal science.
Walters' research program centers on molecular mechanisms of small intestinal function, particularly epithelial cell differentiation and nutrient transport in inflammatory conditions like coeliac disease and Crohn's disease. His seminal contribution redefined chronic Bile Acid Diarrhoea (BAD) pathophysiology: demonstrating that FGF19 hormone deficiency—not malabsorption—drives excessive bile acid synthesis. This paradigm shift underpins current investigations into FXR agonists (e.g., obeticholic acid) as targeted therapies that stimulate FGF19 production. His work extends to diagnostic innovation, establishing that approximately 33% of IBS-D patients actually suffer from BAD (representing ~1% of adults), and developing blood-based C4 testing as alternatives to SeHCAT scans.
Analysis of his 15 most recent publications (2023-2025) reveals obsessive focus on BAD mechanisms and management. Key trends include: (1) microbiome-bile acid interactions (identifying Ruminococcus gnavus and biofilms as diagnostic markers), (2) FGF19/INSL5 hormone dynamics in symptom generation, (3) clinical validation of non-invasive diagnostics (blood C4, fecal profiling), and (4) therapeutic trials of FXR agonists and dietary interventions (8x5 Diet). His work consistently bridges molecular discovery with clinical implementation.
No specific scientific awards are documented in available sources.
Walters actively directs research grants through the Centre for Translational Nutrition and Food Research, though specific funding amounts and student names remain unreported. His leadership in developing European and Canadian clinical guidelines (UEG/ESNM 2022, CAG 2020) demonstrates significant influence on BAD management standards. Current projects emphasize refining diagnostic criteria and developing better-tolerated FXR-targeted therapies.
The Centre for Translational Nutrition and Food Research provides Walters' primary research ecosystem, integrating laboratory science with clinical practice through interdisciplinary collaboration across Imperial College's medical and nutritional sciences divisions.